Asthma Drug Relva Approved In Europe, Japan, But Not The United States – The Inquisitr

Asthma Drug Relva Approved In Europe, Japan, But Not The United States
The Inquisitr
The United States has already approved the new Asthma drug but it's marketed as Breo in the United States. But US doctors are only allowed to prescribe Breo for chronic obstructive pulmonary disease (COPD) while Europe is recommending the new drug for 
Relvar Ellipta Approved in Japan for Treatment of AsthmaBenzinga
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma RTT News
Double asthma approval in Japan lifts SkyePharmaPMLiVE
PharmaTimes –Stock Market Wire –SYS-CON Media (press release)
all 21 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.